Logo image of YCBD

CBDMD INC (YCBD) Stock Price, Forecast & Analysis

USA - NYSEARCA:YCBD - US12482W4087 - Common Stock

0.8745 USD
-0.01 (-0.62%)
Last: 10/31/2025, 8:20:36 PM
0.9187 USD
+0.04 (+5.05%)
After Hours: 10/31/2025, 8:20:36 PM

YCBD Key Statistics, Chart & Performance

Key Statistics
Market Cap7.79M
Revenue(TTM)19.03M
Net Income(TTM)-4850800
Shares8.91M
Float7.48M
52 Week High6.54
52 Week Low0.59
Yearly Dividend0
Dividend YieldN/A
EPS(TTM)-6.03
PEN/A
Fwd PEN/A
Earnings (Next)12-16 2025-12-16/amc
IPO2017-11-17
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


YCBD short term performance overview.The bars show the price performance of YCBD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

YCBD long term performance overview.The bars show the price performance of YCBD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of YCBD is 0.8745 USD. In the past month the price decreased by -24.61%. In the past year, price decreased by -76.18%.

CBDMD INC / YCBD Daily stock chart

YCBD Latest News, Press Relases and Analysis

YCBD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 39.24 816.66B
JNJ JOHNSON & JOHNSON 18.2 454.86B
AZN ASTRAZENECA PLC-SPONS ADR 18.56 255.48B
NVS NOVARTIS AG-SPONSORED ADR 13.83 239.64B
NVO NOVO-NORDISK A/S-SPONS ADR 12.81 219.77B
MRK MERCK & CO. INC. 9.87 214.76B
PFE PFIZER INC 7.27 140.15B
SNY SANOFI-ADR 11.52 123.27B
GSK GSK PLC-SPON ADR 7.73 94.25B
BMY BRISTOL-MYERS SQUIBB CO 7.02 93.77B
ZTS ZOETIS INC 23.17 63.86B
TAK TAKEDA PHARMACEUTIC-SP ADR 48 42.45B

About YCBD

Company Profile

YCBD logo image cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Company Info

CBDMD INC

8845 Red Oak Blvd

Charlotte NORTH CAROLINA 28217 US

CEO: Martin A. Sumichrast

Employees: 42

YCBD Company Website

YCBD Investor Relations

Phone: 17044453060

CBDMD INC / YCBD FAQ

What does CBDMD INC do?

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. The company is headquartered in Charlotte, North Carolina and currently employs 42 full-time employees. The company went IPO on 2017-11-17. The firm has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The firm's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.


What is the current price of YCBD stock?

The current stock price of YCBD is 0.8745 USD. The price decreased by -0.62% in the last trading session.


Does CBDMD INC pay dividends?

YCBD does not pay a dividend.


How is the ChartMill rating for CBDMD INC?

YCBD has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Can you provide the growth outlook for CBDMD INC?

The Revenue of CBDMD INC (YCBD) is expected to decline by -2.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the market cap for CBDMD INC?

CBDMD INC (YCBD) has a market capitalization of 7.79M USD. This makes YCBD a Nano Cap stock.


YCBD Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to YCBD. When comparing the yearly performance of all stocks, YCBD is a bad performer in the overall market: 94.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

YCBD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to YCBD. While YCBD seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

YCBD Financial Highlights

Over the last trailing twelve months YCBD reported a non-GAAP Earnings per Share(EPS) of -6.03. The EPS increased by 71.77% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -49.02%
ROE -79.38%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-132.81%
Sales Q2Q%-10.96%
EPS 1Y (TTM)71.77%
Revenue 1Y (TTM)-7.8%

YCBD Forecast & Estimates

7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 133.28% is expected in the next year compared to the current price of 0.8745.

For the next year, analysts expect an EPS growth of 92.04% and a revenue growth -2.84% for YCBD


Analysts
Analysts82.86
Price Target2.04 (133.28%)
EPS Next Y92.04%
Revenue Next Year-2.84%

YCBD Ownership

Ownership
Inst Owners5.44%
Ins Owners1.71%
Short Float %5.33%
Short Ratio0.09